#oncology

Collection of oncology news, found 175 news.

Ingenuity Systems iReport Now Available: Fast, Accurate, Interactive Report for Gene Expression Data

Ingenuity Systems iReport Now Available: Fast, Accurate, Interactive Report for Gene Expression Data

  • 24th January 2012

-         - iReport Provides Integrated Statistical and Biological Analysis For ...

Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth

Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth

  • 18th January 2012

-         Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced ...

New Variant Analysis Software From Ingenuity Used to Identify DNA Variants for Personalized Medicine

New Variant Analysis Software From Ingenuity Used to Identify DNA Variants for Personalized Medicine

  • 10th January 2012

-     Ingenuity Systems, a leading provider of information and analysis solutions for life science ...

Obesity linked to higher 5-year death rate after esophageal cancer surgery

Obesity linked to higher 5-year death rate after esophageal cancer surgery

  • 21st December 2011

Obesity doubles the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have ...

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

  • 20th November 2011

-         AstraZeneca today announced that the Marketing Authorisation Application ...

On World COPD Day, Patients are Urged to Take Extra Care Ahead of This Winter

On World COPD Day, Patients are Urged to Take Extra Care Ahead of This Winter

  • 16th November 2011

-                 - Updated international ...

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

  • 27th October 2011

-             CMC Biologics today announced the execution of an ...

Abbott to Separate into Two Leading Companies in Diversified Medical Products

Abbott to Separate into Two Leading Companies in Diversified Medical Products

  • 20th October 2011

-     Two publicly traded companies will offer shareholder distinct opportunities given unique ...

Roche and Diagnostica Stago Terminate Partnership

Roche and Diagnostica Stago Terminate Partnership

  • 4th October 2011

-         Roche Professional Diagnostics and Diagnostica Stago announced today that the ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

  • 26th September 2011

-      March 2011 Data Confirm Strong Treatment Effect of ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

  • 5th September 2011

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

  • 5th September 2011

-        - This release is not intended for US ...

BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bl

BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bl

  • 5th September 2011

-        This Release is Not Intended for US Media        ...

CRESTOR Delivers Superior Efficacy in Achievement of Low LDL-C Targets in New VOYAGER Analysis

CRESTOR Delivers Superior Efficacy in Achievement of Low LDL-C Targets in New VOYAGER Analysis

  • 5th September 2011

-        - This release is not intended for US and Canadian media    ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

  • 16th August 2011

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...